NSN 6505-01-227-3570
Part Details | USP CEFTAZIDIME FOR INJECTION
6505-01-227-3570
Alternate Parts: NDC00409508216, NDC00409-5082-16, TAZICEF, NDC25021012720, NDC25021-0127-20, NDC44567023525, NDC44567-0235-25, 6505-01-227-3570, 01-227-3570, 6505012273570, 012273570
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 03, 1986 | 01-227-3570 | 42844 ( CEFTAZIDIME FOR INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-227-3570
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00409-5082-16 | 3VBU6 | HOSPIRA, INC. |
| TAZICEF | 3VBU6 | HOSPIRA, INC. |
| NDC25021-0127-20 | 4RP13 | SAGENT PHARMACEUTICALS, INC. |
| NDC44567-0235-25 | 6XJQ8 | WG CRITICAL CARE, LLC |
Technical Data | NSN 6505-01-227-3570
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BZ1.000 GRAMS CEFTAZIDIME, ANHYDROUS |
| PHYSICAL FORM | POWDER |
| ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 1.000 GRAMS OF ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| FEATURES PROVIDED | STERILE |
| SPECIAL FEATURES | EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 1 GRAM OF CEFTAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME. STORE AT 20 TO 25 C (68 TO 77 F)?SEE USP CONTROLLED ROOM TEMPERATURE|. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION 1GM VIAL 25S |